Detalles de la búsqueda
1.
An exploratory, randomised, placebo-controlled, 14 day trial of the soluble guanylate cyclase stimulator praliciguat in participants with type 2 diabetes and hypertension.
Diabetologia
; 63(4): 733-743, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31858186
2.
Rationale and design for a multicenter, randomized, double-blind, placebo-controlled, phase 2 study evaluating the safety and efficacy of the soluble guanylate cyclase stimulator praliciguat over 12 weeks in patients with heart failure with preserved ejection fraction (CAPACITY HFpEF).
Am Heart J
; 222: 183-190, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32105984
3.
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
JAMA
; 324(15): 1522-1531, 2020 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079154
4.
Left ventricular concentric geometry predicts incident diabetes mellitus independent of established risk factors in the general population: the Copenhagen City Heart Study.
Cardiovasc Diabetol
; 18(1): 37, 2019 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30894177
5.
Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.
Diabetologia
; 61(3): 581-588, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29098323
6.
Expect the Unexpected: SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes and/or Heart Failure.
Cardiology
; 145(5): 321-323, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200379
7.
The role of glycemia in acute heart failure patients.
Clin Chem Lab Med
; 52(10): 1437-46, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24988247
8.
Structural myocardial alterations in diabetes and hypertension: the role of galectin-3.
Clin Chem Lab Med
; 52(10): 1499-505, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24887961
9.
Contrast-induced nephropathy in a patient with type 2 diabetes and coronary artery disease: a case report.
J Int Med Res
; 49(8): 3000605211033177, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34382462
10.
Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control.
Ther Adv Endocrinol Metab
; 11: 2042018820970444, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33489085
11.
Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.
Clin J Am Soc Nephrol
; 16(1): 59-69, 2020 12 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33328269
12.
Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction.
Eur J Prev Cardiol
; 26(1): 72-82, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30335505
13.
Unsupervised high-intensity interval training improves glycaemic control but not cardiovascular autonomic function in type 2 diabetes patients: A randomised controlled trial.
Diab Vasc Dis Res
; 16(1): 69-76, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541346
14.
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail
; 21(5): 553-576, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30989768
15.
Increased left ventricular mass index is present in patients with type 2 diabetes without ischemic heart disease.
Sci Rep
; 8(1): 926, 2018 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29343820
16.
Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.
J Diabetes Res
; 2018: 1631263, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30648112
17.
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail
; 20(5): 853-872, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29520964
18.
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial.
Lancet Diabetes Endocrinol
; 5(5): 333-340, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28330649
19.
Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity.
Int J Endocrinol
; 2015: 390185, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089884
20.
Decreased Insulin Sensitivity and Impaired Fibrinolytic Activity in Type 2 Diabetes Patients and Nondiabetics with Ischemic Stroke.
Int J Endocrinol
; 2015: 934791, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26089903